BOZZALLA CASSIONE, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 290
EU - Europa 247
AS - Asia 50
Continente sconosciuto - Info sul continente non disponibili 3
Totale 590
Nazione #
US - Stati Uniti d'America 288
IE - Irlanda 112
IT - Italia 63
CN - Cina 37
DE - Germania 22
FI - Finlandia 19
AT - Austria 17
IN - India 5
MK - Macedonia 4
SE - Svezia 4
SG - Singapore 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BE - Belgio 2
CA - Canada 2
DK - Danimarca 2
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
SA - Arabia Saudita 1
Totale 590
Città #
Dublin 108
Chandler 77
Ashburn 26
Milan 23
Shanghai 21
Helsinki 19
New York 19
Vienna 16
Princeton 15
Lawrence 14
Beijing 12
Medford 12
Wilmington 9
Pavia 8
Seattle 8
Los Angeles 6
Genoa 4
Sassari 4
Bollate 3
Norwalk 3
Pune 3
Brussels 2
Fairfield 2
Porcia 2
Singapore 2
Tianjin 2
Washington 2
Ann Arbor 1
Baghdad 1
Berlin 1
Boardman 1
Borås 1
Buccinasco 1
Dallas 1
Den Haag 1
Edmonton 1
Esslingen am Neckar 1
Fagnano Olona 1
Falkenstein 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Houston 1
Redwood City 1
Riyadh 1
Tokyo 1
Totale 441
Nome #
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 52
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 47
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 47
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 46
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 45
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 37
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners 34
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 34
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 33
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 33
Established rheumatoid arthritis. The pathogenic aspects. 32
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 30
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 28
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 25
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 23
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 17
Methotrexate and rheumatoid arthritis associated interstitial lung disease 16
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 15
Seronegative rheumatoid arthritis: one year in review 2023 13
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 13
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 9
IgG4-related disease 1
Totale 630
Categoria #
all - tutte 3.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 5 2
2020/202128 2 0 6 2 8 3 0 1 2 0 4 0
2021/202282 2 0 0 0 9 2 1 5 4 2 13 44
2022/2023303 30 26 4 15 20 28 1 24 139 0 10 6
2023/2024209 15 62 7 12 9 42 18 17 5 6 3 13
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 630